CLINICAL STUDIES
Glucose monitoring leads to better outcomes1
Clinical studies show glucose monitoring are associated with better outcomes1. They also indicate that regular glucose testing is essential2, 3 to better manage overall glucose levels and reduce diabetes-related complications. With the FreeStyle Libre system, glucose monitoring is made easier.
FreeStyle Libre improves the frequency of glucose monitoring.
Two clinical studies, IMPACT and REPLACE, demonstrated that T1DM and T2DM FreeStyle Libre users safely and successfully replaced routine SMBG4.
FreeStyle Libre users monitored their glucose almost three times as frequently compared to self-monitored blood glucose (SMBG)4.
FreeStyle Libre users also reduced routine finger pricks by over 90%, with no device-related serious adverse events5, 6, 7.
The FreeStyle Libre system delivers important clinical benefits
The studies showed that T1DM and T2DM FreeStyle Libre users spent less time in hypoglycaemia, had fewer hypoglycaemic episodes per day, and saw no statistically significant increase in HbA1c vs SMBG 5, 6.
Both T1DM and T2DM FreeStyle Libre users spent significantly less time in hypoglycemia
(<3.9 mmol/L)5, 6.
Both T1DM and T2DM FreeStyle Libre users have fewer hypoglycaemic episodes per day
(<3.9 mmol/L)5, 6.
Real-World data from Abbott's FreeStyle Libre show association between higher frequency of glucose monitoring and improved glucose control for people with diabetes8.
More scanning: users checked their glucose levels an average of 16 times a day8.
Reduction in hypoglycemia
Time spent below glucose levels of 3.9 mmol/L, 3.0 mmol/L and 2.5 mmol/L decreased by 15%, 40% and 49%8.
IMPROVED eHbA1c
Average glucose level decreased as scan rate increased, with estimated HbA1c decreasing from 8.0% to 6.7%8.
References:
